DFDurk Fekkes

Durk Fekkes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Durk Fekkes has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Increased CSF levels of aromatic amino acids in hip fracture patients with delirium suggests higher monoaminergic activity

    by Leiv Otto Watne, Ane-Victoria Idland, Durk Fekkes, Johan Raeder, Frede Frihagen, Anette Hylen Ranhoff, Farrukh Abbas Chaudhry, Knut Engedal, Torgeir Bruun Wyller, Bjørnar Hassel

    To examine whether delirium in hip fracture patients was associated with changes in the levels of amino acids and/or monoamine metabolites in cerebrospinal fluid (CSF) and serum. In this prospective cohort study, 77 patients admitted with an acute hip fracture to Oslo University Hospital, Norway, were studied. The concentrations of amino acids in CSF and serum were determined by high performance liquid chromatography. The patients were assessed daily for delirium by the Confusion Assessment Method (pre-operatively and post-operative day 1–5 (all) or until discharge (delirious patients)). Pre-fracture dementia status was decided by an expert panel. Serum was collected pre-operatively and CSF immediately before spinal anesthesia. Fifty-three (71 %) hip fracture patients developed delirium. In hip fracture patients without dementia (n = 39), those with delirium had significantly higher CSF levels of tryptophan (40 % higher), tyrosine (60 % higher), phenylalanine (59 % higher) and the monoamine metabolite 5-hydroxyindoleacetate (23 % higher) compared to those without delirium. The same amino acids were also higher in CSF in delirious patients with dementia (n = 38). The correlations between serum and CSF amino acid levels were poor. Higher CSF levels of monoamine precursors in hip fracture patients with delirium suggest a higher monoaminergic activity in the central nervous system during delirium in this patient group.


  • Open Access

    Cerebrospinal fluid levels of neopterin are elevated in delirium after hip fracture

    by Roanna J. Hall, Leiv Otto Watne, Ane-Victoria Idland, Johan Raeder, Frede Frihagen, Alasdair M. J. MacLullich, Anne Cathrine Staff, Torgeir Bruun Wyller, Durk Fekkes

    The inflammatory cell product neopterin is elevated in serum before and during delirium. This suggests a role for disordered cell-mediated immunity or oxidative stress. Cerebrospinal fluid (CSF) neopterin levels reflect brain neopterin levels more closely than serum levels. Here we hypothesized that CSF neopterin levels would be higher in delirium. In this prospective cohort study, 139 elderly patients with acute hip fracture were recruited in Oslo and Edinburgh. Delirium was diagnosed with the confusion assessment method performed daily pre-operatively and on the first 5 days post-operatively. Paired CSF and blood samples were collected at the onset of spinal anaesthesia. Neopterin levels were measured using high-performance liquid chromatography. Sixty-four (46 %) of 139 hip fracture patients developed delirium perioperatively. CSF neopterin levels were higher in delirium compared to controls (median 29.6 vs 24.7 nmol/mL, p = 0.003), with highest levels in patients who developed delirium post-operatively. Serum neopterin levels were also higher in delirium (median 37.0 vs 27.1 nmol/mL, p = 0.003). CSF neopterin remained significantly associated with delirium after controlling for relevant risk factors. Higher neopterin levels were associated with poorer outcomes (death or new institutionalization) 1 year after surgery (p = 0.02 for CSF and p = 0.03 for serum). This study is the first to examine neopterin in CSF from patients with delirium. Our findings suggest potential roles for activation of cell-mediated immune responses or oxidative stress in the delirium process. High levels of serum or CSF neopterin in hip fracture patients may also be useful in predicting poor outcomes.


  • Open Access

    Potential Influence of Aspirin on Neopterin and Tryptophan Levels in Patients with a Delirium

    by Angelique Egberts, Durk Fekkes, Gijsbertus Ziere, Tischa J. M. Van der Cammen, Francesco U. S. Mattace-Raso

    In an in vitro study, it was found that aspirin might decrease neopterin production and tryptophan degradation. The aim of the present study was to evaluate the possible association between aspirin use and mean neopterin and tryptophan levels in patients with and without a delirium and whether the use of aspirin is associated with a decreased prevalence of delirium. Neopterin and tryptophan levels were determined previously in acutely ill admitted patients aged ≥65 years. The possible influence of aspirin on mean levels of neopterin and tryptophan was investigated with univariate analysis of variance in adjusted models. Eighty-three patients were included; 22 had a delirium. In patients without a delirium (no aspirin (n = 31) versus aspirin (n = 27)), mean neopterin levels were 47.0 nmol/L versus 43.6 nmol/L (p = 0.645) and tryptophan levels were 33.1 µmol/L versus 33.9 µmol/L (p = 0.816). In patients with a delirium (no aspirin (n = 13) versus aspirin (n = 9)), mean neopterin levels were 77.8 nmol/L versus 71.1 nmol/L (p = 0.779) and tryptophan levels were 22.4 µmol/L versus 27.3 µmol/L (p = 0.439). No difference was found in the distribution of aspirin users between patients with and without a delirium. In this study, we found that the use of aspirin had no significant effect on mean levels of neopterin and tryptophan. However, the raw data suggest that there might be a potential influence in patients with a delirium. Aspirin use was not associated with a decreased prevalence of delirium.


  • Open Access

    Tryptophan depletion in chronic fatigue syndrome, a pilot cross-over study

    by Gerard Kh The, Robbert J Verkes, Durk Fekkes, Gijs Bleijenberg, Jos Wm van der Meer, Jan K Buitelaar

    Chronic fatigue syndrome (CFS) is still an enigmatic disorder. CFS can be regarded as a complex disorder with tremendous impact on lives of CFS-patients. Full recovery without treatment is rare. A somatic explanation for the fatigue is lacking. There is clinical and experimental evidence implicating enhanced serotonergic neurotransmission in CFS. Genetic studies and imaging studies support the hypothesis of upregulated serotonin system in CFS. In line with the hypothesis of an increased serotonergic state in CFS, we performed a randomised clinical trial investigated the effect of 5-HT3 receptor antagonism in CFS. No benefit was found of the 5-HT3 receptor antagonist ondansetron compared to placebo. To further investigate the involvement of serotonin in CFS we performed a placebo controlled cross over pilot study investigating the effect of Acute Tryptophan Depletion. Five female CFS-patients who met the US Center for Disease Control and Prevention criteria for CFS were recruited. There were two test days, one week apart. Each participant received placebo and ATD. To evaluate the efficacy of the ATD procedure tryptophan and the large neutral amino acids were measured. The outcome measures were fatigue severity, concentration and mood states. ATD resulted in a significant plasma tryptophan to large neutral amino acid ratio reduction of 96%. There were no significant differences in fatigue-, depression and concentration between the placebo- and ATD condition. These first five CFS-patients did not respond to the ATD procedure. However, a much larger sample size is needed to draw final conclusions on the hypothesis of an increased serotonergic state in the pathophysiology of CFS. ISRCTN07518149


  • Automated Analysis of Primary Amino Acids in Plasma by High-Performance Liquid Chromatography

    by Durk Fekkes

    The concentration of primary amino acids (AAs) in plasma can accurately be determined using high-performance liquid chromatography (HPLC). Before the analysis can be performed, several steps have to be regarded. First, the time and method of blood withdrawal, type of blood tube, use of medication, and differences in dietary intake are important factors that should be standardized. Second, the handling of and the way the blood is transported to the laboratory, the time between blood withdrawal and centrifugation, the method of centrifugation, and the temperature and time of plasma storage have to be noticed. Third, the methods used for deproteinization and derivatization may account for varying results between laboratories. In this chapter, we describe an HPLC method that measures primary amino acids in plasma using automated precolumn derivatization with ortho-phthalaldehyde, and that pays attention to the above-mentioned criteria. This method is relatively fast, simple, sensitive, and reliable. Since with this method we can determine over 40 physiological amino acids with a very good resolution, trace amounts of amino acids can also be determined. In addition, interassay resolution times have very low variation and the use of two internal standards guarantees reliable quantification.


  • Open Access

    Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-α therapy

    by Durk Fekkes, Arthur R. Van Gool, Marjolein Bannink, Stefan Sleijfer, Wim H. J. Kruit, Bronno van der Holt, Alexander M. M. Eggermont, Michiel W. Hengeveld, Gerrit Stoter

    Both increased and decreased nitric oxide (NO) synthesis have been reported in patients treated with interferon-α (IFN-α). Animal studies showed that IFN-α administration results in increased levels of biogenic amines, subsequent activation of monoamine oxidases (MAOs), and finally in a change in NO production due to the H2O2 generated by MAOs. We examined the potential relationship between NO production in plasma and MAO-B activity in platelets of 43 cancer patients during 8 weeks of treatment with IFN-α. NO synthesis was quantitated by measuring both the ratio of citrulline and arginine (CIT/ARG-ratio) and total nitrite/nitrate (NOx) levels. Compared to baseline, MAO activity and NOx increased, while the CIT/ARG-ratio decreased. No associations were found between NOx, MAO and CIT/ARG-ratio. Only few associations were observed between changes in the biochemical parameters and changes in psychopathology induced by IFN-α, of which the association between changes in CIT and lassitude was the most consistent. The results suggest that peripheral NO production and MAO activity are unrelated to each other, and that peripheral changes in these biochemical parameters induced by IFN-α are unlikely to contribute to definite psychiatric disturbance.


  • Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients

    by D. Fekkes, M. Bannink, W. H. J. Kruit, A. R. Van Gool, P. G. H. Mulder, S. Sleijfer, A. M. M. Eggermont, G. Stoter

    The aim of this study was to evaluate the effect of pegylated interferon-alpha (PEG-IFN-α) on the plasma citrulline/arginine ratio, regarded as an index of nitric oxide (NO) synthesis, in patients with high-risk melanoma. Forty patients were randomly assigned to either PEG-IFN-α treatment (n = 22) or to observation only (control group, n = 18). The treatment group received 6 µg PEG-IFN-α/kg once a week during 8 weeks, followed by a maintenance dose of 3 µg/kg/wk. Blood was collected at different time points, plasma concentrations of citrulline and arginine were measured and the ratio of citrulline/arginine was calculated. Patients treated with PEG-IFN-α showed a significant decrease in the concentrations of citrulline and in the citrulline/arginine ratio during the whole study period, both compared to baseline values and to the control group. The data suggest that therapy with PEG-IFN-α results in a marked decrease in the synthesis of NO in melanoma patients.


  • The role of norharman in alcohol dependence and smoking: The potential inhibitory role of norharman on the urge for alcohol and nicotine use

    by Durk Fekkes, Renske Spijkerman, Inge Bongers, Regina van Den Eijnden

    The aim of this study was to investigate the role of the endogenous substance norharman in processes of alcohol and nicotine or tobacco dependence in both humans and animals. For this purpose heavy smokers and excessive alcohol drinkers were recruited, and rats were made dependent on alcohol and nicotine. Plasma concentrations of norharman were measured in drug‐naïve, drug‐free and drug‐taking situations. In addition, craving and nicotine dependence were measured in the group of heavy smokers, while in the animal studies the effect of exogenously administered norharman on the behavioural signs of alcohol and nicotine withdrawal were determined. Humans who abstained from smoking and drinking for a period of 12 h showed normal plasma levels of norharman. Resumption of smoking, but not drinking, generated elevated plasma levels of norharman, especially after smoking self‐made non‐filter cigarettes. Although craving after a period of abstinence was stronger in smokers with high tobacco dependence compared to those with low dependence, the plasma levels of norharman were only negatively related to craving among low nicotine‐dependent smokers. From the animal experiments it was concluded that nicotine intake had no effect on plasma levels of norharman. On the other hand, withdrawal symptoms elicited in nicotine‐dependent rats could be attenuated by exogenous administration of norharman. Rats made alcohol‐dependent by forced intake of an ethanol‐containing diet showed higher norharman levels in plasma and brain compared to alcohol‐naïve rats. This increase is caused by a lower clearance of norharman by the liver of alcohol‐fed rats. After stopping alcohol intake, behavioural signs of alcohol withdrawal occurred which were inhibited by pretreatment with norharman. The results indicate that norharman is involved in processes of alcohol and tobacco dependence and that this substance may be a candidate adjuvant in alleviating abstinence symptoms.


  • Open Access

    The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis

    by Pieter Cj ter Borg, Durk Fekkes, Jan Maarten Vrolijk, Henk R van Buuren

    Background: In primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) fatigue is a major clinical problem. Abnormal amino acid (AA) patterns have been implicated in the development of fatigue in several non-hepatological conditions but for PBC and PSC no data are available. This study aimed to identify abnormalities in AA patterns and to define their relation with fatigue. Methods: Plasma concentrations of tyrosine, tryptophan, phenylalanine, valine, leucine and isoleucine were determined in plasma of patients with PBC (n = 45), PSC (n = 27), chronic hepatitis C (n = 22) and healthy controls (n = 73). Fatigue and quality of life were quantified using the Fisk fatigue severity scale, a visual analogue scale and the SF-36. Results: Valine, isoleucine, leucine were significantly decreased in PBC and PSC. Tyrosine and phenylalanine were increased (p < 0.0002) and tryptophan decreased (p < 0.0001) in PBC. In PBC, but not in PSC, a significant inverse relation between tyrosine concentrations and fatigue and quality of life was found. Patients without fatigue and with good quality of life had increased tyrosine concentrations compared to fatigued patients. Multivariate analysis indicated that this relation was independent from disease activity or severity or presence of cirrhosis. Conclusion: In patients with PBC and PSC, marked abnormalities in plasma AA patterns occur. Normal tyrosine concentrations, compared to increased concentrations, may be associated with fatigue and diminished quality of life.